- Investing Ideas
- /
- Hong Kong Top Growth Stocks
Hong Kong Top Growth Stocks
Results
17
17 companies
Lever Style
Market Cap: HK$788.7m
An investment holding company, engages in the design, production, and trade of garments in the United States, Europe, Oceania, Greater China, and internationally.
1346
HK$1.25
7D
0%
1Y
64.5%
Precision Tsugami (China)
Market Cap: HK$8.1b
An investment holding company, manufactures and sells computer numerical control machine tools primarily in Mainland China and internationally.
1651
HK$21.50
7D
5.9%
1Y
121.2%
BaTeLab
Market Cap: HK$3.9b
Engages in the research, development, and sale of analog integrated circuit (IC) patterned wafers used in packaging and testing solutions in China.
2149
HK$61.45
7D
1.7%
1Y
152.9%
Green Tea Group
Market Cap: HK$5.2b
Operates casual Chinese restaurants in Mainland China.
6831
HK$7.78
7D
8.2%
1Y
n/a
Newborn Town
Market Cap: HK$13.6b
An investment holding company, engages in the social networking business worldwide.
9911
HK$10.16
7D
4.5%
1Y
148.4%
Inspur Digital Enterprise Technology
Market Cap: HK$8.6b
An investment holding company, engages in management software development, cloud services, and sale of Internet of Things (IoT) solutions in the People’s Republic of China.
596
HK$7.51
7D
-8.3%
1Y
115.8%
Beijing Chunlizhengda Medical Instruments
Market Cap: HK$7.1b
Beijing Chunlizhengda Medical Instruments Co., Ltd.
1858
HK$13.06
7D
14.0%
1Y
60.0%
Gushengtang Holdings
Market Cap: HK$8.1b
An investment holding company, provides healthcare services in the People’s Republic of China.
2273
HK$34.15
7D
-1.2%
1Y
-6.7%
Beijing Fourth Paradigm Technology
Market Cap: HK$26.1b
An investment holding company, provides platform-centric artificial intelligence (AI) solutions in the People's Republic of China.
6682
HK$53.00
7D
-0.5%
1Y
0.3%
MicroPort CardioFlow Medtech
Market Cap: HK$2.2b
A medical device company, engages in the research, development, and commercialization of transcatheter and surgical solutions for structural heart diseases in the People’s Republic of China and internationally.
2160
HK$0.92
7D
4.5%
1Y
9.5%
Everest Medicines
Market Cap: HK$20.8b
A biopharmaceutical company, engages in the discovery, license-in, development, and commercialization of therapies and vaccines to address critical unmet medical needs in Greater China and other Asia Pacific markets.
1952
HK$64.05
7D
13.9%
1Y
234.3%
Yadea Group Holdings
Market Cap: HK$39.5b
An investment holding company, engages in the development, manufacture, and sale of electric two-wheeled vehicles and related accessories under the Yadea brand in the People’s Republic of China.
1585
HK$12.98
7D
1.9%
1Y
29.0%
Peijia Medical
Market Cap: HK$4.6b
Engages in the research, development, manufacturing, and sales of transcatheter valve therapeutic and neurointerventional procedural medical devices in the People’s Republic of China.
9996
HK$6.93
7D
10.0%
1Y
193.6%
CanSino Biologics
Market Cap: HK$12.1b
Develops, manufactures, and commercializes vaccines in the People’s Republic of China.
6185
HK$34.75
7D
0.7%
1Y
75.7%
Alphamab Oncology
Market Cap: HK$5.9b
A clinical stage biopharmaceutical company, engages in the research, development, manufacture, and commercialization of oncology biologics.
9966
HK$6.16
7D
-2.2%
1Y
173.8%
Lingbao Gold Group
Market Cap: HK$13.0b
Primarily engages in mining, processing, smelting, refining, and sale of gold products in the People’s Republic of China.
3330
HK$10.12
7D
-2.5%
1Y
216.3%
Cutia Therapeutics
Market Cap: HK$3.0b
An investment holding company, engages in the research, development, manufacture, and commercialization of scalp diseases and care products, and skin care products in the People’s Republic of China and Hong Kong.
2487
HK$9.47
7D
6.8%
1Y
52.0%